In total hip or total knee arthroplasty, hypercoagulability typically begins on the operating table and a hypercoagulable state persists for up to 3 months after surgery. For that reason, it is ...

BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

Venous thromboembolism is a frequent complication of total hip or total knee arthroplasty, with serious clinical and economic consequences. It is largely preventable with adherence to evidence-based ...

The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...

Objectives Venous thromboembolism (VTE) remains highly prevalent among medically ill patients and often leads to increased mortality. Therefore, this study aimed to assess compliance with VTE ...

Please provide your email address to receive an email when new articles are posted on . The proportion of patients receiving low-dose aspirin increased from 7.65% in 2012 to 55.29% in 2022. A low-dose ...

The first clinical use of heparin was for chemoprophylaxis in surgical patients. In 1937, Murray and Crafoord published data evaluating surgical patients who received prophylaxis for DVT. 14 Despite ...

Several factors can increase a person’s risk of deep vein thrombosis (DVT) development. Examples include injury to the veins, hormonal changes, reduced blood flow, certain health conditions, and more.

The American Society of Hematology (ASH) and International Society on Thrombosis and Haemostasis (ISTH) have jointly released their first clinical practice guidelines on anticoagulant prophylaxis for ...